Document is current
Any future updates will be listed below
-
Authors
Mickols, Evgeniya
Meyer, Alina
Handin, Niklas
Stüwe, Malin
Eriksson, Jens
Rudfeldt, Jakob
Blom, Kristin
Fryknäs, Mårten
Sellin, Mikael E.
Lauschke, Volker M.
Karlgren, Maria
Artursson, Per
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 25 January 2024
Accepted: 9 July 2024
First Online: 27 July 2024
Competing interests
: VML is co-founder, CEO and shareholder of HepaPredict AB, as well as co-founder and shareholder of PersoMedix AB. Other authors declare no competing interests.
